Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 3;13(2):307-310.
doi: 10.21037/hbsn-24-3. Epub 2024 Mar 26.

Resection post-radio-embolization in patients with single large hepatocellular carcinoma

Kevin Hakkakian  1 , Nicolas Golse  1   2
Affiliations
Editorial

Resection post-radio-embolization in patients with single large hepatocellular carcinoma

Kevin Hakkakian et al. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Surgery; downstaging; hepatocellular carcinoma (HCC); radio-embolization; transarterial radioembolization (TARE).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-3/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Tzedakis S, Sebai A, Jeddou H, et al. Resection Postradioembolization in Patients With Single Large Hepatocellular Carcinoma. Ann Surg 2023;278:756-62. 10.1097/SLA.0000000000006061 - DOI - PubMed
    1. Baker T, Tabrizian P, Zendejas I, et al. Conversion to resection post radioembolization in patients with HCC: recommendations from a multidisciplinary working group. HPB (Oxford) 2022;24:1007-18. 10.1016/j.hpb.2021.12.013 - DOI - PubMed
    1. Garin E, Tselikas L, Guiu B, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol 2021;6:17-29. 10.1016/S2468-1253(20)30290-9 - DOI - PubMed
    1. Salem R, Gordon AC, Mouli S, et al. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. Gastroenterology 2016;151:1155-1163.e2. 10.1053/j.gastro.2016.08.029 - DOI - PMC - PubMed
    1. Dhondt E, Lambert B, Hermie L, et al. (90)Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial. Radiology 2022;303:699-710. 10.1148/radiol.211806 - DOI - PubMed